Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data validation
1.5 Data sources
1.5.1 Primary
1.5.2 Secondary
1.5.2.1 Paid sources
1.5.2.2 Public sources
Chapter 2 Executive Summary
2.1 Nicotine replacement therapy industry 3600 synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product type trends
2.1.4 Route of administration trends
2.1.5 Mode trends
2.1.6 Distribution channel trends
Chapter 3 Nicotine Replacement Therapy Market Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing cases of cancer globally
3.2.1.2 Increasing smoking cessation initiatives
3.2.1.3 Rising health awareness & education
3.2.2 Industry pitfalls & challenges
3.2.2.1 Associated side effects
3.2.2.2 Stringent regulations and restrictions
3.3 Growth potential analysis
3.3.1 By product type
3.3.2 By route of administration
3.3.3 By mode
3.3.4 By distribution channel
3.4 Regulatory landscape
3.5 Porter’s analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis, 2023
4.3 Competitive analysis of major market players, 2023
4.4 Competitive positioning matrix, 2023
4.5 Strategic dashboard, 2023
Chapter 5 Nicotine Replacement Therapy Market Estimates and Forecast, By Product Type, 2018-2032 (USD Million)
5.1 Key trends, by product type
5.2 Gums
5.3 Lozenges
5.4 Transdermal patches
5.5 Inhalers
5.6 Nasal sprays
5.7 Sublingual tablets
Chapter 6 Nicotine Replacement Therapy Market Estimates and Forecast, By Route of Administration, 2018-2032 (USD Million)
6.1 Key trends, by route of administration
6.2 Oral
6.3 Transdermal
6.4 Nasal
Chapter 7 Nicotine Replacement Therapy Market Estimates and Forecast, By Mode, 2018-2032 (USD Million)
7.1 Key trends, by mode
7.2 Over the counter (OTC)
7.3 Prescription
Chapter 8 Nicotine Replacement Therapy Market Estimates and Forecast, By Distribution Channel, 2018-2032 (USD Million)
8.1 Key trends, by distribution channel
8.2 Hospital pharmacy
8.3 Retail pharmacy
8.4 Online pharmacy
Chapter 9 Nicotine Replacement Therapy Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Pfizer, Inc.
10.2 Glenmark Pharmaceuticals Limited
10.3 Johnson & Johnson
10.4 Cipla Ltd.
10.5 Fertin Pharma
10.6 Rubicon Research Pvt Ltd.
10.7 Sparsh Pharma
10.8 GlaxoSmithKline plc
10.9 Perrigo Company plc
10.10 Pierre Fabre Group
